公司資料
Personalis 股價、新聞與催化劑
- 股票代碼:
- PSNL
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
13.89 USD (-1.07%)
收盤價
最後更新: 2026年8月17日
1.17B USD
市值
股價為何變動
As of Aug 17, 2026, PSNL closed down 1.07% at $13.89. No new same-company headline was identified in the current news window.
公司概覽
Precision-Oncology Genomics
Personalis develops genomic tests for cancer detection, monitoring and therapy development. Its platform uses highly sensitive sequencing and tumor-informed analysis to identify minimal residual disease.
NeXT Personal
NeXT Personal is a personalized circulating-tumor-DNA test designed to detect and track cancer recurrence from blood. Clinical use includes surveillance in lung and breast cancer. Personalis serves physicians through reimbursed clinical testing and pharmaceutical companies through translational research, clinical-trial and biomarker services.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。